Evidence map›Paper›PMID 29183825›Full record

ArticleNeuroscience2018

Chronic Intranasal Oxytocin has Dose-dependent Effects on Central Oxytocin and Vasopressin Systems in Prairie Voles (Microtus ochrogaster).

C D Guoynes, T C Simmons, G M Downing, S Jacob, M Solomon, K L Bales

Abstract read
In one paragraph

Article in Neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Oxytocin and its links through scientific lineage.Comprehensive psychoneuroendocrinology · 2024
    Article
  6. Review
  7. Oxytocin: A developmental journey.Comprehensive psychoneuroendocrinology · 2023
    Review
  8. Article
  9. Article
  10. Oxytocin in Women's Health and Disease.Frontiers in endocrinology · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Sex-dependent regulation of social reward by oxytocin: an inverted U hypothesis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

C D GuoynesDepartment of Psychology and California National Primate Research Center, University of California, Davis, CA, United States; Department of Psychology, University of Wisconsin, Madison, WI, United States.
T C SimmonsDepartment of Psychology and California National Primate Research Center, University of California, Davis, CA, United States.
G M DowningDepartment of Psychology and California National Primate Research Center, University of California, Davis, CA, United States; Department of Biology, San Francisco State University, San Francisco, CA, United States.
S JacobDepartment of Psychiatry and Center for Neurobehavioral Development, University of Minnesota, MN, United States.
M SolomonDepartment of Psychiatry and Behavioral Sciences and MIND Institute, University of California, Davis, CA, United States.
K L BalesDepartment of Psychology and California National Primate Research Center, University of California, Davis, CA, United States. Electronic address: klbales@ucdavis.edu.
University of California, Davis · USUniversity of Minnesota · USUniversity of Wisconsin–Madison · US

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Effects of Chronic Intranasal OxytocinR01HD071998 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BALES, KAREN L. · 2012 to 2016
$4.5M
NICHD NIH HHS R01 HD071998NIH HHS P51 OD011107
6 · The paper itself

Abstract

Oxytocin (Oxt) is a neuropeptide with many functions, including modulation of social behavior(s) and anxiety. Due to its notable pro-social effects, it has been proposed as a treatment in the management of neuropsychiatric disorders, such as autism spectrum disorder (ASD), schizophrenia, and social anxiety; however, effects of long-term daily treatment are still being explored. Previously, we have shown that in male prairie voles (Microtus ochrogaster) exposure to Oxt during the peri-adolescent period impaired adult pair bonding in a dose-dependent fashion. In females, the medium dose used (0.8 IU/kg) appeared to facilitate pair bonding, and the low and medium doses were associated with fewer lines crossed in the open field. In this study, we examined central receptor binding and immunoreactive (IR) protein for Oxt and vasopressin (Avp), a closely related peptide. Voles were treated with saline vehicle, or one of three doses of Oxt (0.08, 0.8, 8.0 IU/kg) for three weeks from postnatal days 21 to 42, and euthanized as adults. We used autoradiography to examine Oxt and Avp receptor binding and immunohistochemistry to examine Oxt and Avp - IR cells in the paraventricular (PVN) and supraoptic (SON) nuclei of the hypothalamus. Females that received the medium dose of Oxt had higher Oxt receptor binding in the nucleus accumbens shell (NAS), while males that received the medium dose had lower Avp-IR cells in the PVN. In summary, we found sex-specific effects of long-term exposure to intranasal Oxt on the Oxt and Avp systems at the weight-adjusted dose currently being used in clinical trials in humans.

Indexed as

Administration, IntranasalAnimalsArvicolinaeAutoradiographyCentral Nervous System AgentsDose-Response Relationship, DrugFemaleImmunohistochemistryMaleOxytocinParaventricular Hypothalamic NucleusRandom AllocationSex CharacteristicsSupraoptic NucleusVasopressinsCentral Nervous System AgentsOxytocinVasopressinsautismintranasaloxytocinvasopressin

Identifiers

PMID29183825
PMCPMC5766367
OpenAlexW2768925059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.